Disruptive Behavior Disorder
📧 Sign up to get email alerts when something new happens for Disruptive Behavior Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Personalizing Psychosocial Intervention for Children With Disruptive Behaviour [NA]
Clinical trial update on a personalized psychosocial intervention for children with disruptive behavior disorders.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project) [NA]
The Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project) clinical trial evaluating treatments for disruptive behavi…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: Strongest Families Finland Canada: Family-based Prevention and Treatment Program of Early Childhood Disruptive Behavior [Phase 1, Phase 2]
This entry reports completion of Phase 1 and Phase 2 trials evaluating the Strongest Families program for early childhood disruptive behavio…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders [Phase 3]
Phase 3 study reporting on the safety of risperidone in children and adolescents with conduct and other disruptive behavior disorders. The u…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation [Phase 3]
Phase 3 study evaluating the safety and effectiveness of risperidone for conduct disorder and other disruptive behavior disorders in childre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation [Phase 3]
Phase 3 trial comparing risperidone to placebo for the treatment of conduct disorder in children with mild to borderline mental retardation;…